CRISIL assigns ‘A2' rating to Gufic's short-term bank facilities

8 Apr 2022 , 09:34 AM

Gufic BioSciences Limited, a leading player in pharmaceuticals, has informed that the credit rating agency CRISIL Limited has reviewed the company’s bank facilities and accordingly assigned ratings to both short-term and long-term facilities.

The total bank facilities reviewed by the company are worth Rs145 crore, which has been enhanced from the existing Rs20 crore.

CRISIL has reaffirmed the credit ratings assigned to long-term facilities at ‘CRISIL BBB+’. However, it has revised the outlook from ‘Stable’ to ‘Positive’.

The rating agency has assigned a ‘CRISIL A2’ rating to the company’s short-term bank facilities.

Gufic BioSciences is currently trading at Rs252.50 apiece down by Rs0.15 or 0.06% from its previous closing of Rs252.65 on the BSE. The scrip opened at Rs252.05 and has touched intraday high and low of Rs255.45 and Rs251.60 respectively.